title: Rapid elimination of circulating leukemia cells with a small dose of alemtuzumab in refractory aggressive NK-cell leukemia.
authors.forename: Makoto
authors.initials: M
authors.lastname: Sasaki
authors.forename: Koichi
authors.initials: K
authors.lastname: Sugimoto
authors.forename: Shimpei
authors.initials: S
authors.lastname: Kawahara
authors.forename: Hajime
authors.initials: H
authors.lastname: Yasuda
authors.forename: Hiroko
authors.initials: H
authors.lastname: Suto
authors.forename: Kazuo
authors.initials: K
authors.lastname: Oshimi
mesh_terms: D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab